Cell culture media, cell separation tools and instruments for life science labs
STEMCELL Technologies makes reagents, primary cells and instruments for stem cell, immunology and cell therapy researchers. Its stack spans hardware design (SolidWorks, Altium, FPGA, C++) alongside a SAP, Salesforce, Magento and Snowflake commercial core, and accelerating, senior-weighted hiring points to scaling protein manufacturing and an APAC finance transformation.
Notable leadership hires: Finance Director
STEMCELL Technologies is a privately held Canadian biotechnology company founded in 1993 and headquartered in Vancouver, BC. It supplies cell culture media, cell isolation products, antibodies, cytokines, small molecules, cryopreservation media, instruments, software and contract services. Customers are researchers working in stem cell biology, immunology, cancer, regenerative medicine and cellular therapy. The company employs 1,001–5,000 people and ships to more than 70 countries through regional offices and distribution centers in Vancouver, Seattle, Grenoble and Singapore.
STEMCELL runs on AWS and GCP with Terraform and CloudFormation, SAP and Workday for back office, Salesforce, Eloqua and Magento for commerce, Snowflake and Tableau for analytics, and SolidWorks, Altium and FPGA for instrument design.
STEMCELL Technologies is headquartered in Vancouver, British Columbia, Canada, with distribution centers in Vancouver, Seattle, Grenoble and Singapore.
Current hiring is spread across Canada, China, the United Kingdom and Australia, with engineering the leading function and openings also in finance, manufacturing, operations and sales.
Other companies in the same industry, closest in size
STEMCELL Technologies's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.